NM_000584.4:c.18C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_000584.4(CXCL8):c.18C>T(p.Ala6Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00157 in 1,613,578 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 4 hom. )
Consequence
CXCL8
NM_000584.4 synonymous
NM_000584.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.25
Publications
7 publications found
Genes affected
CXCL8 (HGNC:6025): (C-X-C motif chemokine ligand 8) The protein encoded by this gene is a member of the CXC chemokine family and is a major mediator of the inflammatory response. The encoded protein is commonly referred to as interleukin-8 (IL-8). IL-8 is secreted by mononuclear macrophages, neutrophils, eosinophils, T lymphocytes, epithelial cells, and fibroblasts. It functions as a chemotactic factor by guiding the neutrophils to the site of infection. Bacterial and viral products rapidly induce IL-8 expression. IL-8 also participates with other cytokines in the proinflammatory signaling cascade and plays a role in systemic inflammatory response syndrome (SIRS). This gene is believed to play a role in the pathogenesis of the lower respiratory tract infection bronchiolitis, a common respiratory tract disease caused by the respiratory syncytial virus (RSV). The overproduction of this proinflammatory protein is thought to cause the lung inflammation associated with csytic fibrosis. This proinflammatory protein is also suspected of playing a role in coronary artery disease and endothelial dysfunction. This protein is also secreted by tumor cells and promotes tumor migration, invasion, angiogenesis and metastasis. This chemokine is also a potent angiogenic factor. The binding of IL-8 to one of its receptors (IL-8RB/CXCR2) increases the permeability of blood vessels and increasing levels of IL-8 are positively correlated with increased severity of multiple disease outcomes (eg, sepsis). This gene and other members of the CXC chemokine gene family form a gene cluster in a region of chromosome 4q. [provided by RefSeq, May 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 4-73740676-C-T is Benign according to our data. Variant chr4-73740676-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 708667.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-2.25 with no splicing effect.
BS2
High AC in GnomAd4 at 199 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CXCL8 | NM_000584.4 | c.18C>T | p.Ala6Ala | synonymous_variant | Exon 1 of 4 | ENST00000307407.8 | NP_000575.1 | |
CXCL8 | NM_001354840.3 | c.18C>T | p.Ala6Ala | synonymous_variant | Exon 1 of 3 | NP_001341769.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00131 AC: 199AN: 152150Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
199
AN:
152150
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00126 AC: 316AN: 250850 AF XY: 0.00130 show subpopulations
GnomAD2 exomes
AF:
AC:
316
AN:
250850
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00160 AC: 2335AN: 1461310Hom.: 4 Cov.: 30 AF XY: 0.00164 AC XY: 1195AN XY: 726982 show subpopulations
GnomAD4 exome
AF:
AC:
2335
AN:
1461310
Hom.:
Cov.:
30
AF XY:
AC XY:
1195
AN XY:
726982
show subpopulations
African (AFR)
AF:
AC:
6
AN:
33412
American (AMR)
AF:
AC:
35
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
AC:
161
AN:
26124
East Asian (EAS)
AF:
AC:
0
AN:
39656
South Asian (SAS)
AF:
AC:
54
AN:
86228
European-Finnish (FIN)
AF:
AC:
14
AN:
53410
Middle Eastern (MID)
AF:
AC:
2
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
1955
AN:
1111646
Other (OTH)
AF:
AC:
108
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
118
236
355
473
591
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00131 AC: 199AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.00129 AC XY: 96AN XY: 74438 show subpopulations
GnomAD4 genome
AF:
AC:
199
AN:
152268
Hom.:
Cov.:
32
AF XY:
AC XY:
96
AN XY:
74438
show subpopulations
African (AFR)
AF:
AC:
20
AN:
41560
American (AMR)
AF:
AC:
10
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
23
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5176
South Asian (SAS)
AF:
AC:
5
AN:
4824
European-Finnish (FIN)
AF:
AC:
1
AN:
10606
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
135
AN:
68022
Other (OTH)
AF:
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
14
28
41
55
69
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
May 21, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.